A case series study on re-treatment to lung cancer after drug-induced interstitial lung disease
S. Terada (Nara, Japan), T. Hajiro (Nara, Japan), H. Yutani (Nara, Japan), M. Ueyama (Nara, Japan), T. Nakanishi (Nara, Japan), N. Hamao (Nara, Japan), T. Inao (Nara, Japan), Y. Kaji (Nara, Japan), T. Yasuda (Nara, Japan), S. Hashimoto (Nara, Japan), E. Tanaka (Nara, Japan), Y. Taguchi (Nara, Japan)
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Terada (Nara, Japan), T. Hajiro (Nara, Japan), H. Yutani (Nara, Japan), M. Ueyama (Nara, Japan), T. Nakanishi (Nara, Japan), N. Hamao (Nara, Japan), T. Inao (Nara, Japan), Y. Kaji (Nara, Japan), T. Yasuda (Nara, Japan), S. Hashimoto (Nara, Japan), E. Tanaka (Nara, Japan), Y. Taguchi (Nara, Japan). A case series study on re-treatment to lung cancer after drug-induced interstitial lung disease. 3668
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: